Cargando…
Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
BACKGROUND: Although immune checkpoint inhibitors (ICIs) are promising in the treatment of advanced cancer, their use is associated with immune-related adverse events (irAEs) that affect endocrine organ systems. Although development of irAEs was associated with improved cancer-specific survival, the...
Autores principales: | Hisanaga, Kaori, Uchino, Hiroshi, Kakisu, Naoko, Miyagi, Masahiko, Yoshikawa, Fukumi, Sato, Genki, Isobe, Kazutoshi, Kishi, Kazuma, Homma, Sakae, Hirose, Takahisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910101/ https://www.ncbi.nlm.nih.gov/pubmed/33654416 http://dx.doi.org/10.2147/DMSO.S289446 |
Ejemplares similares
-
SGLT2 inhibitor versus carbohydrate-restricted isocaloric diet: reprogramming substrate oxidation in type 2 diabetes
por: Igarashi, Hiroyuki, et al.
Publicado: (2023) -
Upregulation of long non‑coding RNA LINC00460 in EGFR‑mutant lung cancer indicates a poor prognosis in patients treated with osimertinib
por: Nakano, Yuta, et al.
Publicado: (2023) -
Sustained fasting glucose oxidation and postprandial lipid oxidation associated with reduced insulin dose in type 2 diabetes with sodium–glucose cotransporter 2 inhibitor: A randomized, open‐label, prospective study
por: Kanazawa, Ken, et al.
Publicado: (2019) -
Giant Cavernous Hemangioma of the Adrenal Gland in an Elderly Patient
por: Hashimoto, Ayana, et al.
Publicado: (2017) -
Determinants of Six-Minute Walk Distance in Idiopathic Pulmonary Fibrosis and Idiopathic Pleuroparenchymal Fibroelastosis
por: Sato, Naofumi, et al.
Publicado: (2022)